drugset
drugset / Trial / NCT00014300

Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme

NCT00014300 ↗

Phase 2 Completed 32 enrolled European Organisation for Research and Treatment of Cancer - EORTC
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of glufosfamide in treating patients who have recurrent glioblastoma multiforme.

Timeline

Start
2001-01
Primary completion
2001-09
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Glufosfamide Small molecule — Intravenous

Indications

central nervous system neoplasm